Sandesara PB, Virani SS, Fazio S, Shapiro MD. The forgotten lipids: triglycerides, remnant cholesterol, and atherosclerotic cardiovascular disease risk. Endocr Rev. 2019;40:537–57.

Article  PubMed  Google Scholar 

Raja V, Aguiar C, Alsayed N, Chibber YS, ElBadawi H, Ezhov M, et al. Non-HDL-cholesterol in dyslipidemia: review of the state-of-the-art literature and outlook. Atherosclerosis. 2023;383:117312.

Article  CAS  PubMed  Google Scholar 

Joshi PH, Khokhar AA, Massaro JM, Lirette ST, Griswold ME, Martin SS, et al. Remnant lipoprotein cholesterol and incident coronary heart disease: The Jackson Heart and Framingham offspring cohort studies. J Am Heart Assoc. 2016;5:e002765.

Article  PubMed  PubMed Central  Google Scholar 

Fujioka Y, Ishikawa Y. Remnant lipoproteins as strong key particles to atherogenesis. J Atheroscler Thromb. 2009;16:145–54.

Article  CAS  PubMed  Google Scholar 

Varbo A, Benn M, Tybjærg-Hansen A, Nordestgaard BG. Elevated remnant cholesterol causes both low-grade inflammation and ischemic heart disease, whereas elevated low-density lipoprotein cholesterol causes ischemic heart disease without inflammation. Circulation. 2013;128:1298–309.

Article  CAS  PubMed  Google Scholar 

Ohnishi H, Saitoh S, Takagi S, Ohata J, Isobe T, Kikuchi Y, et al. Relationship between insulin-resistance and remnant-like particle cholesterol. Atherosclerosis. 2002;164:167–70.

Article  CAS  PubMed  Google Scholar 

Varbo A, Benn M, Tybjærg-Hansen A, Jørgensen AB, Frikke-Schmidt R, Nordestgaard BG. Remnant cholesterol as a causal risk factor for ischemic heart disease. J Am Coll Cardiol. 2013;61:427–36.

Article  CAS  PubMed  Google Scholar 

Park C, Fang J, Hawkins NA, Wang G. Comorbidity status and annual total medical expenditures in U.S. hypertensive adults. Am J Prev Med. 2017;53:S172–s81.

Article  PubMed  PubMed Central  Google Scholar 

Matsubara K, Yamamoto Y, Sonoyama K, Igawa G, Furuse M, Yatsuhashi T, et al. Current status of lipid management of hypertensive patients. Hypertens Res. 2003;26:699–704.

Article  CAS  PubMed  Google Scholar 

Satoh A, Adachi H, Tsuruta M, Hirai Y, Hiratsuka A, Enomoto M, et al. High plasma level of remnant-like particle cholesterol in the metabolic syndrome. Diabetes care. 2005;28:2514–8.

Article  CAS  PubMed  Google Scholar 

Kasahara A, Adachi H, Hirai Y, Enomoto M, Fukami A, Yoshikawa K, et al. High level of plasma remnant-like particle cholesterol may predispose to development of hypertension in normotensive subjects. Am J Hypertens. 2013;26:793–8.

Article  CAS  PubMed  Google Scholar 

Guo D-C, Gao JW, Wang X, Chen Z-T, Gao Q-Y, Chen Y-X, et al. Remnant cholesterol and risk of incident hypertension: a population-based prospective cohort study. Hypertens Res. 2024 https://doi.org/10.1038/s41440-023-01558-7.

Saha S, Bornstein SR, Graessler J, Kopprasch S. Very-low-density lipoprotein mediates transcriptional regulation of aldosterone synthase in human adrenocortical cells through multiple signaling pathways. Cell Tissue Res. 2012;348:71–80.

Article  CAS  PubMed  Google Scholar